Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


20.10.2025

1 Adv Sci (Weinh)
1 Ann Med
1 Biochem Genet
3 BMC Cancer
1 BMC Complement Med Ther
2 BMC Infect Dis
1 BMC Psychol
2 BMC Womens Health
1 BMJ Open
1 Br J Radiol
1 Brachytherapy
1 Cancer Cell Int
1 Cancer Radiother
3 Cancers (Basel)
1 Cell Mol Life Sci
1 Cochrane Database Syst Rev
1 Discov Oncol
4 Eur J Obstet Gynecol Reprod Biol
2 Eur J Public Health
1 Exp Ther Med
1 FASEB J
1 Front Biosci (Landmark Ed)
1 Front Immunol
2 Front Oncol
1 Future Microbiol
1 Future Oncol
1 Health Rep
2 Int J Cancer
1 Int J Gen Med
1 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
1 Int J Hyperthermia
4 Int J Mol Sci
1 Iran J Pharm Res
1 J Cachexia Sarcopenia Muscle
1 J Cancer Res Clin Oncol
1 J Clin Med
1 J Comput Biol
1 J Infect Dis
1 J Int AIDS Soc
1 J Liq Biopsy
1 J Med Virol
1 JAMA Netw Open
1 JCO Glob Oncol
1 JMIR Public Health Surveill
1 Liver Transpl
1 Med Glas (Zenica)
1 Med Oncol
1 Molecules
2 N Engl J Med
1 Obstet Gynecol
1 Oncologist
1 Phys Med
3 PLoS One
1 Public Health Pract (Oxf)
2 Quant Imaging Med Surg
1 Rev Bras Ginecol Obstet
1 Rev Med Suisse
4 Sci Rep
2 Virol J


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Sci (Weinh)

  1. ZHEN Q, Xu Y, Xu Y, Liu X, et al
    Erucic Acid, Derived by Lactobacillus Crispatus, Induces Ferroptosis in Cervical Cancer Organoids Through the PPAR-delta Signaling Pathway.
    Adv Sci (Weinh). 2025 Oct 13:e12599. doi: 10.1002/advs.202512599.
    PubMed         Abstract available


    Ann Med

  2. CHEN R, Ye C, Li Y, Lin Z, et al
    The distribution of colposcopy directed ectocervical biopsy and endocervical curettage results: a retrospective study of 47,134 cases.
    Ann Med. 2025;57:2573149.
    PubMed         Abstract available


    Biochem Genet

  3. RAHIMI-MOGHADDAM A, Ghorbanmehr N, Gharbi S
    Dual Inhibition of PI3K-AKT Signaling Pathway by miR-542 Overexpression in Cervical Cancer.
    Biochem Genet. 2025 Oct 13. doi: 10.1007/s10528-025-11257.
    PubMed         Abstract available


    BMC Cancer

  4. SETSOAFIA EA, Sarfo-Annan G, Daniels J, Addae J, et al
    Experiences of patients with cervical cancer undergoing concurrent chemoradiation therapy at the Korle-Bu teaching hospital in Ghana: an explorative qualitative study.
    BMC Cancer. 2025;25:1547.
    PubMed         Abstract available

  5. TESFOM HN, Gizaw M, Yilam M, Klein JMA, et al
    Prevalence and factors associated with high-risk human papillomavirus infection and cervical lesions among women with HIV in Addis Ababa, Ethiopia.
    BMC Cancer. 2025;25:1557.
    PubMed         Abstract available

  6. JIANG P, Wei S, Li C, Qu A, et al
    Safety and efficacy of toripalimab plus concurrent chemoradiotherapy for locally advanced cervical cancer: a single-arm, phase Ib trial.
    BMC Cancer. 2025;25:1566.
    PubMed         Abstract available


    BMC Complement Med Ther

  7. MORIASI G, Ngugi M, Mwitari P, Omwenga G, et al
    Promising anti-cervical cancer efficacy and phytochemical analysis of Vitex doniana Sweet (Verbenaceae) leaf extracts: an in vitro investigation with molecular mechanisms of action.
    BMC Complement Med Ther. 2025;25:379.
    PubMed         Abstract available


    BMC Infect Dis

  8. ZHOU J, Su LJ, Chen J, Hu HB, et al
    Cervical conization and high risk - HPV status changes in relation to menopause: a retrospective longitudinal study based on generalized additive mixed models.
    BMC Infect Dis. 2025;25:1322.
    PubMed         Abstract available

  9. LEMA TF, Moleki M, Mosalo A
    Epidemiology of human papillomavirus infection of the uterine cervix among women in Adama, Ethiopia: a cross-sectional study.
    BMC Infect Dis. 2025;25:1277.
    PubMed         Abstract available


    BMC Psychol

  10. ALTUNTAS CALIM G, Elmas S
    Do women's personality traits influence their beliefs about cervical cancer screening: a descriptive-correlational study in a sample from Turkiye.
    BMC Psychol. 2025;13:1141.
    PubMed         Abstract available


    BMC Womens Health

  11. SILVA LGSD, Silva PVS, Chaves MFD, Cruz ACDC, et al
    Interval between diagnosis and treatment of cervical cancer in Brazil: comparative analysis of cases with and without diagnosis prior to arrival at the hospital unit.
    BMC Womens Health. 2025;25:485.
    PubMed         Abstract available

  12. SASSENOU J, Ringa V, Zins M, Ozguler A, et al
    Underuse, overuse, and guideline-based use of cervical cancer screening: social disparities in temporal screening trajectories in the French CONSTANCES cohort.
    BMC Womens Health. 2025;25:495.
    PubMed         Abstract available


    BMJ Open

  13. ZHAO Q, Ruan G, Ye Z, Meng Y, et al
    County-level colposcopy attendance in China's national cervical cancer screening programme: a cross-sectional ecological study of Fujian province.
    BMJ Open. 2025;15:e101866.
    PubMed         Abstract available


    Br J Radiol

  14. ISHIGURO T, Saida T, Minami M, Mori K, et al
    MRI localization evaluation to distinguish gastric-type adenocarcinoma and lobular endocervical glandular hyperplasia from other cystic lesions.
    Br J Radiol. 2025 Aug 4:tqaf191. doi: 10.1093.
    PubMed         Abstract available


    Brachytherapy

  15. PY JF, Renard S, Gehin W, Martz N, et al
    Good safety of oblique needle insertion using the Venezia applicator for cervical cancer: A single-center cohort study.
    Brachytherapy. 2025 Oct 14:S1538-4721(25)00304.
    PubMed         Abstract available


    Cancer Cell Int

  16. ALMARS AI
    Green-synthesized MnFe(2)O(4)/GO nanocomposites: structural characterization, cytotoxicity, and potential for targeted cervical cancer therapy.
    Cancer Cell Int. 2025;25:355.
    PubMed         Abstract available


    Cancer Radiother

  17. CHARGARI C, Ducassou A, Laville A, Lucia F, et al
    Radiotherapy and brachytherapy for cervical cancer: Recommendations of the Societe francaise de radiotherapie oncologique.
    Cancer Radiother. 2025;29.
    PubMed         Abstract available


    Cancers (Basel)

  18. YOUSEFIRIZI F, Hajianfar G, Sabouri M, Holloway C, et al
    Pre-Treatment PET Radiomics for Prediction of Disease-Free Survival in Cervical Cancer.
    Cancers (Basel). 2025;17:3218.
    PubMed         Abstract available

  19. GALANI A, Zikopoulos A, Moustakli E, Potiris A, et al
    Cervical Cancer Screening in the HPV-Vaccinated and Digital Era: Reassessing Strategies in Light of Artificial Intelligence and Evolving Risk.
    Cancers (Basel). 2025;17:3179.
    PubMed         Abstract available

  20. BAUTISTA-SEBASTIAN E, Cortes-Morales VA, Fajardo-Orduna GR, Monroy-Garcia A, et al
    Interaction Between Mesenchymal Stromal Cells and Tumor Cells Present in Cervical Cancer Influences Macrophage Polarization.
    Cancers (Basel). 2025;17:3099.
    PubMed         Abstract available


    Cell Mol Life Sci

  21. PENG X, Zhu Y, Han Y, Cai C, et al
    Enhancing anti-tumor immunity by targeting BATF and the STAT1/PD-L1 pathway in cervical carcinoma.
    Cell Mol Life Sci. 2025;82:353.
    PubMed         Abstract available


    Cochrane Database Syst Rev

  22. KIETPEERAKOOL C, Rattanakanokchai S, Shawky M, Morrison J, et al
    Simple hysterectomy with pelvic lymphadenectomy versus radical hysterectomy with pelvic lymphadenectomy for women with stage IA2-IB1 cervical cancer.
    Cochrane Database Syst Rev. 2025;10:CD012335.
    PubMed         Abstract available


    Discov Oncol

  23. LU L, Li Z, Qiang P, Shao Y, et al
    Gut microbiota and risk of cervical cancer: a Mendelian multivariable randomization study.
    Discov Oncol. 2025;16:1912.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  24. BRUN JL, Bergeron C, Averous G, Ardaens K, et al
    Management of women with abnormal cervical cytology: Update of French guidelines after the implementation of HPV screening.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114661.
    PubMed         Abstract available

  25. MCKEOWN C, Kumar P, Cheung M, Marchocki Z, et al
    Beyond the transformation zone: Outcomes in the management of CGIN over five years.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114712.
    PubMed         Abstract available

  26. XU X, Cruickshank ME, Woolner AMF
    The impact of human papillomavirus (HPV) vaccination on the risk of adverse obstetric outcomes: a data linkage study.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114678.
    PubMed         Abstract available

  27. ZHAO Q, Lv S, Liu F
    Combined therapy for LSIL with HR-HPV: CO(2) laser and interferon alpha2a.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114686.
    PubMed         Abstract available


    Eur J Public Health

  28. SEVILLA-DEDIEU C, Le Guern M, Coquoz C, Billaudeau N, et al
    Which women go for screening?
    Eur J Public Health. 2025;35:992-998.
    PubMed         Abstract available

  29. LUCAS E, Dimitrova N, Tomatis M, Sheridan B, et al
    Creating a data processing warehouse to support performance monitoring of cancer screening programmes in Europe using a common set of indicators.
    Eur J Public Health. 2025;35:977-983.
    PubMed         Abstract available


    Exp Ther Med

  30. WANG F, Jiang X, Wang P
    [Retracted] NF-kappaB interaction long non-coding RNA inhibits migration, invasion and epithelial-mesenchymal transition of cervical cancer cells through inhibiting NF-kappaB signaling pathways.
    Exp Ther Med. 2025;30:234.
    PubMed         Abstract available


    FASEB J

  31. ZHANG Y, Lu J, Qi M, Zhang X, et al
    CDK11 Promotes Paclitaxel Resistance in Cervical Cancer by Regulating LATS1-Mediated Hippo Signaling Pathway Through Phosphorylation of NF2.
    FASEB J. 2025;39:e71085.
    PubMed         Abstract available


    Front Biosci (Landmark Ed)

  32. ZHAO Y, Zhao C, Zhao J, Ma Y, et al
    Excavation of Molecular Subtypes of Cervical Cancer Based on DNA Methylation Patterns.
    Front Biosci (Landmark Ed). 2025;30:45025.
    PubMed         Abstract available


    Front Immunol

  33. YUAN Y, Sun D, Yang M, Xia Y, et al
    Profiling of immune cell subsets and functional characteristics of cervical cancer based on single cell RNA sequencing.
    Front Immunol. 2025;16:1658705.
    PubMed         Abstract available


    Front Oncol

  34. LIU Y, Shi Y, Zhang Y, Hua K, et al
    A novel bivariate nomogram for predicting sequela vaginal lesions after surgery in patients with HPV-associated cervical cancer.
    Front Oncol. 2025;15:1587520.
    PubMed         Abstract available

  35. YANG J, Ji J, Ni X, Li Y, et al
    Explorations of predictors for parametrial invasion and how it affects treatment strategy for bulky cervical cancer.
    Front Oncol. 2025;15:1660495.
    PubMed         Abstract available


    Future Microbiol

  36. LI Y, Wei X, Li Y
    Recombinant lactococcus lactis expressing HPV-16 E6E7 dual antigens for potential cervical cancer treatment enhances dendritic cell vaccines efficacy.
    Future Microbiol. 2025 Oct 14:1-11. doi: 10.1080/17460913.2025.2567700.
    PubMed         Abstract available


    Future Oncol

  37. SOZIB SI, Smail L, Jassim GA
    Knowledge, attitudes, and practices regarding HPV infection, cervical cancer, and HPV vaccination among Emirati women.
    Future Oncol. 2025 Oct 15:1-11. doi: 10.1080/14796694.2025.2575519.
    PubMed         Abstract available


    Health Rep

  38. GARASZCZUK R, Yong JHE, Coldman A, Garner R, et al
    The OncoSim-Cervix cancer microsimulation model: Unveiling roll-out strategies for human papillomavirus primary testing.
    Health Rep. 2025;36:15-26.
    PubMed         Abstract available


    Int J Cancer

  39. YU X, Nzoutchoum OL, Gao D, Hsu CD, et al
    Cervical cancer screening and prevalence among older US Medicare beneficiaries with and without HIV.
    Int J Cancer. 2025 Oct 13. doi: 10.1002/ijc.70193.
    PubMed         Abstract available

  40. CHINULA L, Chagomerana MB, Mkochi T, Msowoya L, et al
    Single visit screen-triage-treat strategy using GeneXpert-based HPV testing of self-collected cervicovaginal samples and thermal ablation treatment for cervical cancer prevention among women in Lilongwe, Malawi.
    Int J Cancer. 2025 Oct 16. doi: 10.1002/ijc.70177.
    PubMed         Abstract available


    Int J Gen Med

  41. HUANG G, Ye X, Chen X
    The Efficacy of Evidence-Based Nursing Interventions in Postoperative Care for Cervical Cancer Patients: A Retrospective Evaluation.
    Int J Gen Med. 2025;18:6073-6082.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  42. URBANO FP, Cury GR, Dos Santos CR, da Silva DJC, et al
    Introduction of DNA-HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not fit the budget.
    Int J Gynaecol Obstet. 2025 Oct 14. doi: 10.1002/ijgo.70594.
    PubMed         Abstract available


    Int J Gynecol Cancer

  43. MATSUO K, Matsuzaki S, Nagase Y, Keymeulen S, et al
    Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2025;35:102674.
    PubMed         Abstract available


    Int J Hyperthermia

  44. YANG Y, Shi W, Zhang M, Gong X, et al
    Cervical morphology and elasticity following treatment of cervical squamous intraepithelial lesions with focused ultrasound vs. loop electrosurgical excision procedure: a prospective non-randomized controlled study.
    Int J Hyperthermia. 2025;42:2570825.
    PubMed         Abstract available


    Int J Mol Sci

  45. LADOUKAKIS E, Andriamiadana G, Hajizadah F, James LGE, et al
    Epigenetic Biomarkers for Cervical Cancer Progression: A Scoping Review.
    Int J Mol Sci. 2025;26:9423.
    PubMed         Abstract available

  46. MAIMON T, Trink Y, Goldberger J, Kalisky T, et al
    Unsupervised Machine Learning Reveals Temporal Components of Gene Expression in HeLa Cells Following Release from Cell Cycle Arrest.
    Int J Mol Sci. 2025;26:9491.
    PubMed         Abstract available

  47. MEDINA BUENO GA, Jaramillo Saavedra EA, Torres Rendon N, Huareccallo Suni DD, et al
    Predictive Factors for Cervical Intraepithelial Neoplasia in Women with Abnormal Cytology According to Human Papillomavirus Genotype: An Observational Study.
    Int J Mol Sci. 2025;26:9612.
    PubMed         Abstract available

  48. COSTA MT, Neto BV, da Silva JB, Carvalho L, et al
    Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior.
    Int J Mol Sci. 2025;26:9796.
    PubMed         Abstract available


    Iran J Pharm Res

  49. YANG S, Zeng L, Deng C, Tian X, et al
    Anti-tumor Effects of Hedyotis diffusa Willd on Cervical Cancer: Inhibition of Proliferation, Migration, and Induction of Apoptosis.
    Iran J Pharm Res. 2025;24:e159390.
    PubMed         Abstract available


    J Cachexia Sarcopenia Muscle

  50. TUNINETTI V, Virano E, Calvo A, Carbone V, et al
    Peripheral Thyroid Hormones, Inflammatory and Skeletal Muscle Indexes in Advanced Cervical Cancer Treated With Cemiplimab.
    J Cachexia Sarcopenia Muscle. 2025;16:e70101.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  51. MATHIBELA SP, Ncube KN, Lebelo MT, Steenkamp V, et al
    Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology.
    J Cancer Res Clin Oncol. 2025;151:294.
    PubMed         Abstract available


    J Clin Med

  52. ESPIAS-ALONSO M, Gorostidi M, Zapardiel I, Gracia M, et al
    Assessment of ESGO Quality Indicators and Factors Associated with Recurrence Following Surgery for Early-Stage Cervical Cancer: A Retrospective Cohort Study.
    J Clin Med. 2025;14:7041.
    PubMed         Abstract available


    J Comput Biol


  53. Corrigendum to: CerviNet: A Novel Approach for Cervical Cancer Classification Using Pap-Smear Images.
    J Comput Biol. 2025;32:986.
    PubMed        


    J Infect Dis

  54. JIMENEZ NR, Mancilla V, Laniewski P, Herbst-Kralovetz MM, et al
    Immunometabolic Contributions of Atopobiaceae Family Members in Human Papillomavirus Infection, Cervical Dysplasia, and Cancer.
    J Infect Dis. 2025;232:767-778.
    PubMed         Abstract available


    J Int AIDS Soc

  55. PELLEGRINO RA, Tu S, Ville-Benavides R, Jalil EM, et al
    Incidence and outcomes of anal and cervical cancer among adults with HIV in Latin America: a retrospective cohort study.
    J Int AIDS Soc. 2025;28:e70050.
    PubMed         Abstract available


    J Liq Biopsy

  56. NJANGIRU IK, Tayeb BA, Ali H, Kamil RM, et al
    Liquid biopsy biomarkers in cervical cancer: A systematic review and meta-analysis.
    J Liq Biopsy. 2025;10:100328.
    PubMed         Abstract available


    J Med Virol

  57. LIU M, Huang X, Feng Q
    Human Papillomavirus 42: A Novel Sublineage Identification, and Comparative Analysis of HPV42 Genetic Variability Present in Cervical Cell and Digital Papillary Adenocarcinoma.
    J Med Virol. 2025;97:e70640.
    PubMed         Abstract available


    JAMA Netw Open

  58. PRADHAN P, Iyer HS, Rebbeck TR
    Geographic and Temporal Patterns of Screening for Breast, Cervical, and Colorectal Cancer in the US, 1997-2019.
    JAMA Netw Open. 2025;8:e2537905.
    PubMed         Abstract available


    JCO Glob Oncol

  59. YERRAM PS, Mwita CJ, Mwaiselage J, Elul B, et al
    Association Between the Test-and-Treat Strategy and the Severity of Cervical Dysplastic Lesions Among Women Living With HIV in Tanzania (2015-2023).
    JCO Glob Oncol. 2025;11:e2400540.
    PubMed         Abstract available


    JMIR Public Health Surveill

  60. CHEN Z, Lin E, Chen M, Wang S, et al
    Temporal Trends in Cervical Human Papillomavirus Prevalence Among Females in Xiamen, China (2016-2023): Cross-Sectional Study.
    JMIR Public Health Surveill. 2025;11:e70507.
    PubMed         Abstract available


    Liver Transpl

  61. RAMAKRISHNAN P, Blomker J, Cooke K, Bowler T, et al
    Cervical cancer screening remains low in liver transplant patients regardless of demographics: A single-center review.
    Liver Transpl. 2025 Oct 14. doi: 10.1097/LVT.0000000000000748.
    PubMed        


    Med Glas (Zenica)

  62. CAMDZIC N, Brkic A, Mameledzija E, Babic M, et al
    Prevalence of cervical cytology abnormalities and its correlation with human papillomavirus infection: a single- institution five-year experience.
    Med Glas (Zenica). 2025;22:258-262.
    PubMed         Abstract available


    Med Oncol

  63. LAHOUTI S, Doustvandi MA, Yari A, Eslami M, et al
    Photodynamic therapy boosts the anti-proliferative activity of oxaliplatin in cervical cancer cells by regulating stemness-related genes.
    Med Oncol. 2025;42:514.
    PubMed         Abstract available


    Molecules

  64. ARIZMENDI-IZAZAGA A, Navarro-Tito N, Campos-Viguri GE, Jimenez-Wences H, et al
    Exometabolome and Molecular Signatures Associated with HPV 16 in Cervical Cancer: Integrative Metabolomic and Transcriptomic Analysis for Biomarker Discovery.
    Molecules. 2025;30:3909.
    PubMed         Abstract available


    N Engl J Med

  65. TU H, Huang H, Li Y, Chen X, et al
    Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.
    N Engl J Med. 2025;393:1463-1474.
    PubMed         Abstract available

  66. BIXEL K
    Sentinel Lymphadenectomy for Early-Stage Cervical Cancer - the New Standard?
    N Engl J Med. 2025;393:1534-1536.
    PubMed        


    Obstet Gynecol

  67. FALLAH PN, Bowman P, Tran C, Chen V, et al
    Implementation of Human Papillomavirus Self-Collection and Barriers to Follow-Up Among Unhoused Individuals in Texas: The EMPOWER Study.
    Obstet Gynecol. 2025;146:710-717.
    PubMed         Abstract available


    Oncologist

  68. YANG XL, Wei LC, He JL, Wang TJ, et al
    Different prognosis for stage IIB cervical cancer patients with unilateral or bilateral parametrial invasion treated with concurrent chemoradiotherapy.
    Oncologist. 2025 Oct 16:oyaf329. doi: 10.1093.
    PubMed         Abstract available


    Phys Med

  69. WANG Z, Yun Q, Zhang T, Sun X, et al
    Dosimetric advantages of a novel X-Ray/gamma-Ray integrated radiotherapy platform in cervical carcinoma: A comparative treatment planning study.
    Phys Med. 2025;138:105098.
    PubMed         Abstract available


    PLoS One

  70. LARSSON GL, Carlsson J, Helenius G, Bergengren L, et al
    Molecular triage on HPV-positive samples in a cervical screening setting.
    PLoS One. 2025;20:e0333539.
    PubMed         Abstract available

  71. CHOU HH, Chu PY, Wu YH, Feng C, et al
    Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan.
    PLoS One. 2025;20:e0333757.
    PubMed         Abstract available

  72. ZHANG Z, Li Y, Huang H, Wei T, et al
    Disparities and trends of the incidence and mortality of female-specific cancers in the United States.
    PLoS One. 2025;20:e0334128.
    PubMed         Abstract available


    Public Health Pract (Oxf)

  73. WASHINGTON A, Houck KF, Nelson BW, Harper DM, et al
    Black US women share their experiences with follow-up after abnormal cervical cancer screening.
    Public Health Pract (Oxf). 2025;10:100658.
    PubMed         Abstract available


    Quant Imaging Med Surg

  74. MEI W, Li C, Tang Q, Sang L, et al
    Prospective comparison of synthetic high b-value field of view optimized and constrained undistorted multiplexed sensitivity encoding (FOCUS-MUSE) and FOCUS diffusion-weighted imaging in evaluating cervical cancer.
    Quant Imaging Med Surg. 2025;15:10006-10019.
    PubMed         Abstract available

  75. LIU L, Pan L, Zou C, Zhang F, et al
    Reliability study of MRI in detecting lymph node metastasis of cervical cancer: a multi-center retrospective study result analysis.
    Quant Imaging Med Surg. 2025;15:9559-9570.
    PubMed         Abstract available


    Rev Bras Ginecol Obstet

  76. PAVARINO TTG, Guimaraes ICCDV, Oliveira CA, Viviani SCA, et al
    The occurrence of cervical high-grade lesions in women outside the recommended age screening.
    Rev Bras Ginecol Obstet. 2025;47:e-rbgo41.
    PubMed         Abstract available


    Rev Med Suisse

  77. MURTAS M, Rolland-Guillard L, Hu K, Wisniak A, et al
    [HPV self-sampling and cervical cancer screening].
    Rev Med Suisse. 2025;21:1827-1831.
    PubMed         Abstract available


    Sci Rep

  78. DAVID C, El-Zein M, Franco EL, Szyf M, et al
    Enhancing the sensitivity of non-invasive cervical cancer detection using CpG methylation haplotype profiling.
    Sci Rep. 2025;15:36057.
    PubMed         Abstract available

  79. HUANG S, Wang R, Song Y, Liao S, et al
    Uncovering the anti-cervical cancer mechanism of Ziyuglycoside I via integrated network pharmacology molecular docking and experimental validation.
    Sci Rep. 2025;15:36258.
    PubMed         Abstract available

  80. MOHAMMADI MM, Karimi Z, Shirani M, Elyasi S, et al
    A model testing study of cervical cancer screening behavior using rogers's protection motivation theory.
    Sci Rep. 2025;15:36260.
    PubMed         Abstract available

  81. ZHANG C, Jia D, Wang Z
    Computer-assisted quantitative framework for whole slide cervical image grading driven by time series features.
    Sci Rep. 2025;15:35596.
    PubMed         Abstract available


    Virol J

  82. ZENG S, Hu L, Ding W, Cao X, et al
    The most common combination of co-infections genotypic distribution and clearance patterns of high-risk human papillomavirus in Southern China: a population-based retrospective study.
    Virol J. 2025;22:327.
    PubMed         Abstract available

  83. YE M, Yan D, Xu J, Liu D, et al
    Human papillomavirus prevalence and genotype distribution among 30,147 screened women and 3,362 cervical cancer patients in China: a retrospective study.
    Virol J. 2025;22:323.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.